Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Serum zinc level in depressed patients during zinc supplementation of imipramine treatment.

Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G.

J Affect Disord. 2010 Nov;126(3):447-52. doi: 10.1016/j.jad.2010.04.024. Epub 2010 May 20.

PMID:
20493532
2.

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.

Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G.

J Affect Disord. 2009 Nov;118(1-3):187-95. doi: 10.1016/j.jad.2009.02.014. Epub 2009 Mar 10.

PMID:
19278731
3.
4.

Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.

Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.

Pharmacopsychiatry. 2004 Jan;37(1):18-25.

PMID:
14750044
5.

Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.

Serrano-Blanco A, Gabarron E, Garcia-Bayo I, Soler-Vila M, Caramés E, Peñarrubia-Maria MT, Pinto-Meza A, Haro JM; Depressió en Atenció Primària de Gavà Group (D. A. P. G. A.).

J Affect Disord. 2006 Apr;91(2-3):153-63. Epub 2006 Feb 3.

PMID:
16458976
6.

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

Tulen JH, Volkers AC, van den Broek WW, Bruijn JA.

J Clin Psychopharmacol. 2006 Oct;26(5):542-4. No abstract available.

PMID:
16974207
7.

Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW.

J Clin Psychiatry. 1998 Dec;59(12):657-63.

PMID:
9921699
8.

Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.

Tignol J, Pujol-Domenech J, Chartres JP, Léger JM, Plétan Y, Tonelli I, Tournoux A, Pezous N.

Acta Psychiatr Scand. 1998 Feb;97(2):157-65.

PMID:
9517912
9.

Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.

Shahal B, Piel E, Mecz L, Kremer I, Klein E.

Biol Psychiatry. 1996 Dec 1;40(11):1181-3. No abstract available.

PMID:
8931923
10.

Treatment of mood-congruent psychotic depression with imipramine.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW.

J Affect Disord. 2001 Oct;66(2-3):165-74.

PMID:
11578669
11.
12.

Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats.

Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Łupina T, Ossowska G.

Pharmacol Rep. 2007 Jan-Feb;59(1):46-52.

13.

Alpha-1-acid glycoprotein in major depressive disorder. Relationships to severity, response to treatment and imipramine plasma levels.

Nieto E, Vieta E, Alvarez L, Torra M, Colom F, Gastó C.

J Affect Disord. 2000 Aug;59(2):159-64.

PMID:
10837884
14.

A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.

van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P.

Psychopharmacology (Berl). 2004 Oct;175(4):481-6.

PMID:
15243735
15.

Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression.

Bekaroğlu M, Değer O, Karahan SC, Bilici M, Soylu C, Orem A.

J Affect Disord. 2000 Sep;59(3):175-82.

PMID:
10854634
16.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
17.

Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients.

Forlenza OV, Stoppe Júnior A, Hirata ES, Ferreira RC.

Sao Paulo Med J. 2000 Jul 6;118(4):99-104.

18.

A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.

Lopez-Ibor JJ, Conesa A; Spanish Milnacipran/Imipramine Study.

Curr Med Res Opin. 2004 Jun;20(6):855-60.

PMID:
15200743
20.

A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression.

Van Amerongen AP, Ferrey G, Tournoux A.

J Affect Disord. 2002 Oct;72(1):21-31.

PMID:
12204314

Supplemental Content

Support Center